Methadone N-demethylation in human liver microsomes: lack of stereoselectivity and involvement of CYP3A4

di Foster, David J R, Somogyi, Andrew A, Bochner, Felix
Pubblicazione 1999

Differential in vitro inhibition of M3G and M6G formation from morphine by (R)- and (S)-methadone and structurally related opioids

di Morrish, Glynn A, Foster, David J R, Somogyi, Andrew A
Pubblicazione 2006

Rosiglitazone Metabolism in Human Liver Microsomes Using a Substrate Depletion Method

di Bazargan, Maryam, Foster, David J. R., Davey, Andrew K., Muhlhausler, Beverly S.
Pubblicato in Drugs R D (2017)

Population pharmacokinetics of (R)-, (S)- and rac-methadone in methadone maintenance patients

di Foster, David J R, Somogyi, Andrew A, White, Jason M, Bochner, Felix
Pubblicazione 2004

Population Pharmacokinetic Modeling of Itraconazole and Hydroxyitraconazole for Oral SUBA-Itraconazole and Sporanox Capsule Formulations in Healthy Subjects in Fed and Fasted State...

di Abuhelwa, Ahmad Y., Foster, David J. R., Mudge, Stuart, Hayes, David, Upton, Richard N.
Pubblicato in Antimicrob Agents Chemother (2015)

Pharmacokinetics of caspofungin acetate to guide optimal dosing in cats

di Leshinsky, Jana, McLachlan, Andrew, Foster, David J. R., Norris, Ross, Barrs, Vanessa R.
Pubblicato in PLoS One (2017)

CYP2D6 and CYP3A4 involvement in the primary oxidative metabolism of hydrocodone by human liver microsomes

di Hutchinson, Mark R, Menelaou, Andrew, Foster, David J R, Coller, Janet K, Somogyi, Andrew A
Pubblicazione 2004

Steady-state pharmacokinetics of (R)- and (S)-methadone in methadone maintenance patients

di Foster, David J R, Somogyi, Andrew A, Dyer, Kyle R, White, Jason M, Bochner, Felix
Pubblicazione 2000

A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquine

di Wojciechowski, Jessica, Wiese, Michael D, Proudman, Susanna M, Foster, David J R, Upton, Richard N
Pubblicato in Br J Clin Pharmacol (2015)

A model‐based evaluation of single metrics for discriminating changes in rheumatoid arthritis disease activity

di Wojciechowski, Jessica, Wiese, Michael D., Proudman, Susanna M., Foster, David J. R., Upton, Richard N.
Pubblicato in Br J Clin Pharmacol (2016)

Comparison of tincture of opium and methadone to control opioid withdrawal in a Thai treatment centre

di Jittiwutikarn, Jaroon, Ali, Robert, White, Jason M, Bochner, Felix, Somogyi, Andrew A, Foster, David J R
Pubblicazione 2004

(R)- and (S)-methadone and buprenorphine concentration ratios in maternal and umbilical cord plasma following chronic maintenance dosing in pregnancy

di Gordon, Andrea L, Lopatko, Olga V, Somogyi, Andrew A, Foster, David J R, White, Jason M
Pubblicazione 2010

Blood–brain equilibration kinetics of levo-α-acetyl-methadol using a chronically instrumented sheep preparation

di Foster, David J R, Jensen, Mette L, Upton, Richard N, Somogyi, Andrew A, Grant, Cliff, Martinez, Allison
Pubblicazione 2005

Population Pharmacokinetic Model of Doxycycline Plasma Concentrations Using Pooled Study Data

di Hopkins, Ashley M., Wojciechowski, Jessica, Abuhelwa, Ahmad Y., Mudge, Stuart, Upton, Richard N., Foster, David J. R.
Pubblicato in Antimicrob Agents Chemother (2017)

Association between obesity and remission in rheumatoid arthritis patients treated with disease-modifying anti-rheumatic drugs

di Abuhelwa, Ahmad Y., Hopkins, Ashley M., Sorich, Michael J., Proudman, Susanna, Foster, David J. R., Wiese, Michael D.
Pubblicato in Sci Rep (2020)

Development of a physiologically based pharmacokinetic model for intravenous lenalidomide in mice

di Hughes, Jim H., Upton, Richard N., Reuter, Stephanie E., Rozewski, Darlene M., Phelps, Mitch A., Foster, David J. R.
Pubblicato in Cancer Chemother Pharmacol (2019)

Genetic polymorphism of CYP1A2 but not total or free teriflunomide concentrations is associated with leflunomide cessation in rheumatoid arthritis

di Hopkins, Ashley M., Wiese, Michael D., Proudman, Susanna M., O'Doherty, Catherine E., Upton, Richard N., Foster, David J. R.
Pubblicato in Br J Clin Pharmacol (2015)

Concomitant beta-blocker use is associated with a reduced rate of remission in patients with rheumatoid arthritis treated with disease-modifying anti-rheumatic drugs: a post hoc mu...

di Abuhelwa, Ahmad Y., Foster, David J. R., Manning-Bennett, Arkady, Sorich, Michael J., Proudman, Susanna, Wiese, Michael D., Hopkins, Ashley M.
Pubblicato in Ther Adv Musculoskelet Dis (2021)

Pharmacometrics in Australasia—Twenty Years of Population Approach Group of Australia and New Zealand

di Hennig, Stefanie, Hannam, Jacqueline A., Kirkpatrick, Carl M.J., Staatz, Christine E., Holford, Sam, Duffull, Stephen B., Al‐Sallami, Hesham S., Charles, Bruce G., Holford, Nick, Foster, David J.R.
Pubblicato in CPT Pharmacometrics Syst Pharmacol (2019)

Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies

di Hughes, Jim H., Phelps, Mitch A., Upton, Richard N., Reuter, Stephanie E., Gao, Yue, Byrd, John C., Grever, Michael R., Hofmeister, Craig C., Marcucci, Guido, Blum, William, Blum, Kristie A., Foster, David J.R.
Pubblicato in Br J Clin Pharmacol (2019)